1/12
08:34 am
hae
Haemonetics (NYSE:HAE) had its price target raised by analysts at Barrington Research from $90.00 to $93.00. They now have an "outperform" rating on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its price target raised by analysts at Barrington Research from $90.00 to $93.00. They now have an "outperform" rating on the stock.
1/12
04:26 am
hae
EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics [Yahoo! Finance]
Low
Report
EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics [Yahoo! Finance]
1/12
01:48 am
hae
EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics
Low
Report
EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics
1/9
07:03 pm
hae
Vivasure Medical Announces Acquisition by Haemonetics Corporation [Yahoo! Finance]
Low
Report
Vivasure Medical Announces Acquisition by Haemonetics Corporation [Yahoo! Finance]
1/9
08:38 am
hae
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Medium
Report
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
1/9
08:00 am
hae
Vivasure Medical Announces Acquisition by Haemonetics Corporation
Medium
Report
Vivasure Medical Announces Acquisition by Haemonetics Corporation
1/9
06:15 am
hae
Haemonetics Acquires Vivasure Medical Limited
Low
Report
Haemonetics Acquires Vivasure Medical Limited
1/7
06:17 pm
hae
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
Low
Report
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
1/2
06:00 am
hae
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference
12/25
07:53 am
hae
Do You Believe in the Long-Term Growth Potential of Haemonetics Corporation (HAE)? [Yahoo! Finance]
Low
Report
Do You Believe in the Long-Term Growth Potential of Haemonetics Corporation (HAE)? [Yahoo! Finance]
12/17
08:05 am
hae
Haemonetics (NYSE:HAE) had its price target raised by analysts at Mizuho from $75.00 to $90.00. They now have an "outperform" rating on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its price target raised by analysts at Mizuho from $75.00 to $90.00. They now have an "outperform" rating on the stock.
12/16
08:28 am
hae
Riverwater Partners Small Cap Strategy Sold Its Stake in Haemonetics Corporation (HAE) in Q3 [Yahoo! Finance]
Low
Report
Riverwater Partners Small Cap Strategy Sold Its Stake in Haemonetics Corporation (HAE) in Q3 [Yahoo! Finance]
12/16
05:44 am
hae
Haemonetics (NYSE:HAE) was upgraded by analysts at CJS Securities to a "strong-buy" rating.
Low
Report
Haemonetics (NYSE:HAE) was upgraded by analysts at CJS Securities to a "strong-buy" rating.
12/15
12:01 pm
hae
Haemonetics (NYSE:HAE) was given a new $99.00 price target on by analysts at Robert W. Baird.
Low
Report
Haemonetics (NYSE:HAE) was given a new $99.00 price target on by analysts at Robert W. Baird.
12/15
07:20 am
hae
Haemonetics (NYSE:HAE) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.
Low
Report
Haemonetics (NYSE:HAE) was downgraded by analysts at Needham & Company LLC from a "buy" rating to a "hold" rating.
12/14
01:26 am
hae
Medium
Report
12/12
03:21 pm
hae
Haemonetics (NYSE:HAE) had its price target raised by analysts at JPMorgan Chase & Co. from $62.00 to $74.00. They now have a "neutral" rating on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its price target raised by analysts at JPMorgan Chase & Co. from $62.00 to $74.00. They now have a "neutral" rating on the stock.
11/21
08:05 am
hae
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Medium
Report
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
11/14
07:22 am
hae
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
11/7
10:46 am
hae
Haemonetics Is Still Undervalued, Even After The Rally [Seeking Alpha]
Low
Report
Haemonetics Is Still Undervalued, Even After The Rally [Seeking Alpha]
11/7
08:20 am
hae
Haemonetics (NYSE:HAE) had its price target raised by analysts at Barrington Research from $86.00 to $90.00. They now have an "outperform" rating on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its price target raised by analysts at Barrington Research from $86.00 to $90.00. They now have an "outperform" rating on the stock.
11/7
08:07 am
hae
Haemonetics (NYSE:HAE) had its price target raised by analysts at Needham & Company LLC from $68.00 to $78.00. They now have a "buy" rating on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its price target raised by analysts at Needham & Company LLC from $68.00 to $78.00. They now have a "buy" rating on the stock.
11/6
02:03 pm
hae
Haemonetics (NYSE:HAE) had its price target raised by analysts at BTIG Research from $85.00 to $88.00. They now have a "buy" rating on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its price target raised by analysts at BTIG Research from $85.00 to $88.00. They now have a "buy" rating on the stock.
11/6
06:17 am
hae
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website [Yahoo! Finance]
Medium
Report
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website [Yahoo! Finance]
11/6
06:12 am
hae
Haemonetics Non-GAAP EPS of $1.27 beats by $0.16, revenue of $327M beats by $15.51M [Seeking Alpha]
Low
Report
Haemonetics Non-GAAP EPS of $1.27 beats by $0.16, revenue of $327M beats by $15.51M [Seeking Alpha]